Nieto Y - Search Results

1

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.

Pasvolsky O, Milton DR, Rauf M, Ghanem S, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Rezvani K, Champlin R, Shpall EJ, Lin P, Qazilbash MH. Pasvolsky O, et al. Among authors: nieto y. Blood Cancer J. 2023 May 3;13(1):68. doi: 10.1038/s41408-023-00842-6. Blood Cancer J. 2023. PMID: 37137874 Free PMC article.

2

High-dose chemotherapy in gynecologic malignancies.

Nieto Y, Cagnoni PJ, Shpall EJ. Nieto Y, et al. Cancer Treat Res. 1998;95:277-85. doi: 10.1007/978-1-4615-5447-9_10. Cancer Treat Res. 1998. PMID: 9619289 Review. No abstract available.

3

Autologous stem-cell transplantation for solid tumors in adults.

Nieto Y, Shpall EJ. Nieto Y, et al. Hematol Oncol Clin North Am. 1999 Oct;13(5):939-68, vi. doi: 10.1016/s0889-8588(05)70104-0. Hematol Oncol Clin North Am. 1999. PMID: 10553256 Review.

4

Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer.

Nieto Y, Cagnoni PJ, Bearman SI, Shpall EJ, Matthes S, Jones RB. Nieto Y, et al. Biol Blood Marrow Transplant. 2000;6(2A):198-203. doi: 10.1016/s1083-8791(00)70043-7. Biol Blood Marrow Transplant. 2000. PMID: 10816028 Free article.

5

High-dose chemotherapy for breast cancer.

Nieto Y, Shpall EJ. Nieto Y, et al. Cancer Treat Res. 2000;103:77-114. doi: 10.1007/978-1-4757-3147-7_5. Cancer Treat Res. 2000. PMID: 10948443 Review. No abstract available.

6

Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer.

McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A, Stoltz J, Russell P, McDermitt J, Hogan C, Murphy J, Shpall EJ. McNiece I, et al. Among authors: nieto y. Blood. 2000 Nov 1;96(9):3001-7. Blood. 2000. PMID: 11049977 Free article. Clinical Trial.

7

High-dose chemotherapy for breast cancer: is another look warranted?

Nieto Y, Jones RB, Shpall EJ. Nieto Y, et al. Curr Opin Oncol. 2004 Mar;16(2):114-9. doi: 10.1097/00001622-200403000-00005. Curr Opin Oncol. 2004. PMID: 15075901 Review.

8

Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy.

Nieto Y, Nawaz S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Nieto Y, et al. Clin Cancer Res. 2004 Apr 15;10(8):2609-17. doi: 10.1158/1078-0432.ccr-03-0536. Clin Cancer Res. 2004. PMID: 15102662

9

Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.

Nieto Y, Franklin WA, Jones RB, Berman SI, Pellom J, Barón AE, Shpall EJ. Nieto Y, et al. Biol Blood Marrow Transplant. 2004 Jun;10(6):415-25. doi: 10.1016/j.bbmt.2004.02.004. Biol Blood Marrow Transplant. 2004. PMID: 15148495 Free article.

10

Stem-cell transplantation for the treatment of advanced solid tumors.

Nieto Y, Jones RB, Shpall EJ. Nieto Y, et al. Springer Semin Immunopathol. 2004 Nov;26(1-2):31-56. doi: 10.1007/s00281-004-0160-8. Epub 2004 Sep 11. Springer Semin Immunopathol. 2004. PMID: 15368078 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page